8YY Biolidics
- 0.010
- 0.0000.00%
Biolidics News
Biolidics Names Ex-Weiye Executive as Financial Controller
Biolidics (SGX: 8YY) appointed Lau Wei Kian as the company's financial controller, effective July 1, according to a Thursday filing on the Singapore Exchange. Kian, a resident of Singapore, brings exp
Biolidics' CEO Steps Down; Shares Surge 10%
Biolidics (SGX:8YY) chief executive officer and director, Song Tang Yih will step down from his position, effective, June 30, to pursue other career opportunities, according to a filing with the Singa
Biolidics Places Subsidiary Under Voluntary Liquidation
Biolidics (SGX:8YY) said that it will be placing its indirectly wholly owned subsidiary, Biomedics Laboratory, under creditor's voluntary liquidation, a filing with the Singapore Exchange said on Mond
Biolidics First Quarter 2024 Earnings: S$0.001 Loss per Share (Vs S$0.001 Loss in 1Q 2023)
Bioldics' Financial Controller Steps Down
Biolidics (SGX:8YY) financial controller, Siu Yeung Sau resigned from his position, effective June 1, to "pursue other career opportunities," a filing with the Singapore Exchange said on Friday. The c
Singapore Shares Drop in Red Despite Global Rally; Biolidics Surges 20% on Wider Losses in Q1
Singapore's Straits Times Index slipped into the red zone on Wednesday, despite an overnight global rally following US inflation data that topped expectations. During the day, the benchmark Singapore
Biolidics' Q1 Loss Widens as Revenue Slumps; Stock Surges 20%
Biolidics (SGX:8YY) posted a wider attributable loss in the first quarter after revenue plummeted past 96% from a year earlier, according to a Tuesday filing with the Singapore Exchange. The medical d
Biolidics: Financial Statements and Related Announcement-First Quarter Results
Biolidics Flags Cybersecurity Incident; Shares Surge 10%
Biolidics (SGX:8YY) revealed that the group's payroll software vendor has been hacked by a hacker group that identified itself as GHOSTR Hacker Group, according to a filing with the Singapore Exchange
Biolidics Ltd Announces Executive Board Reshuffle
Biolidics Ltd Announces Major Board Restructuring
Biolidics Appoints New Executive Director
Singapore Shares Fall at Market Close; Biolidics Up 9%
Singapore's Strait Times Index fell on Friday, following data released on economic growth and the central bank's decision to keep its monetary policy unchanged. During the day, the benchmark Singapore
Biolidics' Loss Narrows in 2023 as Revenue Slumps 47%; Shares Surge 9%
Biolidics (SGX:8YY) booked an attributable loss of SG$2.5 million for the year ended Dec. 31, 2023, compared with an attributable loss of SG$9.4 million in the year-ago period, according to the compan
Biolidics Ltd. Prepares for Executive Stock Issuance
Biolidics Ltd. Eyes Diversification Into Tech Lifestyle Sector
Biolidics to Issue Shares Worth Over SG$360,000 to New Director
Biolidics (SGX:8YY) will issue 33.5 million shares valued at SG$368,656 to a newly appointed executive director who will be supporting the strategic direction of the group's new technology-enabled ent
Biolidics Ltd Welcomes New Executive With Equity Stake
Biolidics Full Year 2023 Earnings: S$0.004 Loss per Share (Vs S$0.033 Loss in FY 2022)
Biolidics Issues Over 87 Million Shares to Sponsor, Investor
Biolidics (SGX:8YY) allotted and issued over 87 million shares on Thursday, which will be listed and quoted on the Singapore bourse on or about Jan. 15. Of these shares, 83 million shares were issued
Analysis
Price Target
No Data
